Stoptussin Tablets 4 mg / 100 mg, # 20
Category
Cough
,
Thinning phlegm
,
Expectorants
Scope of the drug
Respiratory system
Release form
Tablet
Manufacturer country
Czech
Package quantity, pcs
twenty
Stopussin tab.
4mg / 100mg No. 20
Name ENG
STOPTUSSIN
Clinical and pharmacological group
Drug with antitussive and expectorant action
ATX code
Antitussives in combination with expectorant drugs
Dosage
4 mg / 100 mg
Structure
1 tablet contains: Active ingredients: butamirate citrate 4 mg
guaifenesin 100 mg
Excipients: colloidal silicon dioxide
mannitol
MCC
glyceryl tribegenate
magnesium stearate.
Indications
Dry cough and irritating cough of various etiologies (including with infectious and inflammatory diseases of the upper and lower respiratory tract).
Storage conditions and periods
Store in a dark place at a temperature of 10-25 ° C.
Shelf life 5 years
...
Contraindications
hypersensitivity to the components of the drug
myasthenia gravis
children up to 12 years old for tablets, up to 6 months for drops for oral administration
I trimester of pregnancy
lactation period.
INN / Active ingredient
Butamirate, Guaifenesin
Specifications
Category
Cough
,
Thinning phlegm
,
Expectorants
Scope of the drug
Respiratory system
Release form
Tablet
Manufacturer country
Czech
Package quantity, pcs
twenty
Scope of application
Pulmonology
Minimum age from
12 years
Way of introduction
Through the mouth
Vacation conditions
Without recipe
Brand name
Teva
The amount of the dosage form in the primary package
10 pieces.
Primary packaging type
Blister
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Antitussive + expectorant
Dosage form
Pills
Packaging
Box
Expiration date in days
1826
The target audience
Adult
Dosage (volume) of the substance in the preparation
butamirate citrate 4.0 mg
guaifenesin 100.0 mg
Package weight, g
15
Mode of application
:
Inside, after a meal. < br> The tablets are taken whole, without chewing, with a liquid (water, tea, fruit juice). < br> For adults and children over 12 years of age, the drug is dosed depending on the patient's body weight: less than 50 kg - 1 / 2 tablets 4 times a day
50–70 kg - 1 tablet 3 times a day
70–90 kg - 1.5 tablets 3 times a day
more than 90 kg - 1.5 tab.
4 times a day. < br> The interval between doses should be 4-6 hours. < br> < br>
Anatomical and therapeutic characteristics
:
R05FB02 Antitussives in combination with expectorant drugs